This unique dual-receptor activation reduces hunger, prolongs the sensation of fullness, and enhances blood sugar control, making it effective for weight loss
The clinical trial program for tirzepatide included extensive safety monitoring across multiple large-scale studies involving thousands of participants
But there are ways to minimize nausea, which typically goes away once your body gets used to the medication, so dont rule out taking Ozempic in the morning if thats your concern
doi: 10.1001/jamapediatrics.2024.3812
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist available in the US under two brand names: Mounjaro (for type 2 diabetes in adults) and Zepbound (for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity)
After a subcutaneous dose, GH tends to peak within roughly 40 minutes and return toward baseline within about 23 hours, reflecting a brief ~2 hour half-life [4]